Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × antineoplaston AS 2-1 × Clear all

NCT00003452 2017-09-28

Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

Phase 2 Terminated

Urinary Bladder Neoplasms